Home

CEVEC Pharmaceuticals is a leading provider of high-performance cell technology for the manufacturing of advanced biotherapeutics from R&D to manufacturing scale.

The company’s product portfolio comprises platform technologies for gene therapy viral vectors, viral vaccines, Exosomes and complex recombinant proteins. ELEVECTA® is specifically designed for AAV manufacturing, while CAP® addresses Adenoviral vectors, Lentiviral vectors, Oncolytic viruses and Exosomes. CAP®Go is the platform of choice for complex recombinant proteins.

STABLE AAV PRODUCER CELL LINES

VIRAL VECTORS, VACCINES AND EXOSOMES

GLYCO-OPTIMIZED PROTEINS

BIO INTERNATIONAL CONVENTION

JUNE 6 – JUNE 11 | FULLY DIGITAL

Please contact the CEVEC Team via the virtual Partnering Platform.

NEWSLETTER

Subscribe for the CEVEC Newsletter according to our Privacy Policy to receive the latest CEVEC News,
including Press Releases, Conference Information and Webinar Invitations.

© CEVEC Pharmaceuticals GmbH 2020